Clinical Trials Browser

Fibrosis × Liver Transplantation × Gastrointestinal × Clear all

NCT05027425 2024-11-22

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

Phase 2 Active not recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal

NCT04499833 2022-06-06

HepatoPredict

Phase NA Recruiting

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Recurrence

NCT01387503 2021-10-11

Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging

Phase NA Completed

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular